Let’s start up with the current stock price of Baudax Bio Inc. (BXRX), which is $1.04 to be very precise. The Stock rose vividly during the last session to $1.00 after opening rate of $0.99 while the lowest price it went was recorded $0.97 before closing at $1.00.
Recently in News on December 17, 2020, Baudax Bio Announces $12 Million Offering Priced at a Premium to Market. Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, (“Baudax Bio” or the “Company”) today announced that it has entered into a definitive agreement with a healthcare-focused institutional investor for the purchase and sale of an aggregate of 10,300,430 shares of common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to an aggregate of 10,300,430 shares of common stock at a purchase price of $1.165 per share (or $1.155 per prefunded warrant) and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules. The warrants have an exercise price of $1.18 per share, are exercisable immediately, and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about December 21, 2020, subject to the satisfaction of customary closing conditions. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Baudax Bio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.1400 on 02/21/20, with the lowest value was $0.9700 for the same time period, recorded on 12/22/20.
Baudax Bio Inc. (BXRX) full year performance was -85.57%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Baudax Bio Inc. shares are logging -89.74% during the 52-week period from high price, and 7.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.97 and $10.14.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1541129 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Baudax Bio Inc. (BXRX) recorded performance in the market was -85.57%, having the revenues showcasing -68.29% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 29.60M, as it employees total of 24 workers.
Market experts do have their say about Baudax Bio Inc. (BXRX)
During the last month, 0 analysts gave the Baudax Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.1507, with a change in the price was noted -2.5700. In a similar fashion, Baudax Bio Inc. posted a movement of -70.99% for the period of last 100 days, recording 1,352,788 in trading volumes.
Technical breakdown of Baudax Bio Inc. (BXRX)
Raw Stochastic average of Baudax Bio Inc. in the period of last 50 days is set at 4.35%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 25.81%. In the last 20 days, the company’s Stochastic %K was 12.13% and its Stochastic %D was recorded 7.25%.
Bearing in mind the latest performance of Baudax Bio Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -85.57%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -73.85%, alongside a downfall of -85.57% for the period of the last 12 months. The shares increased approximately by -4.88% in the 7-day charts and went up by -5.77% in the period of the last 30 days. Common stock shares were lifted by -68.29% during last recorded quarter.